Scholarly Index
Angiolo Gadducci
University of Pisa; 14,147 total citations; 812 total publications; best world rank #57
University of Pisa
14,147Total citations
812Total publications
66H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Endometrial and Cervical Cancer Treatments | Lifetime | 69 | IT 10 | 99.49 |
| Ovarian cancer diagnosis and treatment | Lifetime | 118 | IT 11 | 99.36 |
| Intraperitoneal and Appendiceal Malignancies | Lifetime | 57 | IT 12 | 99.08 |
| Cervical Cancer and HPV Research | Lifetime | 292 | IT 13 | 98.50 |
| Endometriosis Research and Treatment | Lifetime | 248 | IT 40 | 98.39 |
| Uterine Myomas and Treatments | Lifetime | 182 | IT 38 | 98.51 |
| Sarcoma Diagnosis and Treatment | Lifetime | 645 | IT 50 | 97.70 |
| Colorectal and Anal Carcinomas | Lifetime | 466 | IT 22 | 97.21 |
| PARP inhibition in cancer therapy | Lifetime | 298 | IT 12 | 96.24 |
| Multiple and Secondary Primary Cancers | Lifetime | 552 | IT 45 | 94.88 |
| Testicular diseases and treatments | Lifetime | 506 | IT 30 | 95.28 |
| Gestational Trophoblastic Disease Studies | Lifetime | 257 | IT 10 | 92.03 |
| Male Breast Health Studies | Lifetime | 604 | IT 73 | 63.93 |
| Ovarian cancer diagnosis and treatment | 2021-2025 | 206 | IT 36 | 96.64 |
| Endometrial and Cervical Cancer Treatments | 2021-2025 | 471 | IT 89 | 93.10 |
| PARP inhibition in cancer therapy | 2021-2025 | 609 | IT 41 | 84.34 |